DE3869789D1 - Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha. - Google Patents

Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.

Info

Publication number
DE3869789D1
DE3869789D1 DE8888300407T DE3869789T DE3869789D1 DE 3869789 D1 DE3869789 D1 DE 3869789D1 DE 8888300407 T DE8888300407 T DE 8888300407T DE 3869789 T DE3869789 T DE 3869789T DE 3869789 D1 DE3869789 D1 DE 3869789D1
Authority
DE
Germany
Prior art keywords
interferon
alpha
treatment
gamma
leukaemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE8888300407T
Other languages
English (en)
Inventor
Paul Philip Trotta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21712239&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3869789(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE3869789D1 publication Critical patent/DE3869789D1/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8888300407T 1987-01-20 1988-01-19 Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha. Revoked DE3869789D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US473187A 1987-01-20 1987-01-20

Publications (1)

Publication Number Publication Date
DE3869789D1 true DE3869789D1 (de) 1992-05-14

Family

ID=21712239

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888300407T Revoked DE3869789D1 (de) 1987-01-20 1988-01-19 Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.

Country Status (7)

Country Link
EP (1) EP0276120B1 (de)
JP (1) JPS63198636A (de)
AT (1) ATE74517T1 (de)
CA (1) CA1321348C (de)
DE (1) DE3869789D1 (de)
ES (1) ES2039276T3 (de)
GR (1) GR3004928T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2704546B2 (ja) * 1989-04-04 1998-01-26 光利 太良 Ａｔｌｌ治療用吸入剤
TWI375679B (en) 2003-10-14 2012-11-01 Hoffmann La Roche Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication
NZ594105A (en) 2005-07-25 2013-02-22 Intermune Inc Novel macrocyclic inhibitors of hepatitis c virus replication
ATE493409T1 (de) 2005-10-11 2011-01-15 Intermune Inc Verbindungen und verfahren zur inhibierung der replikation des hepatitis-c-virus
CU23432B6 (es) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562024A (en) * 1978-10-31 1980-05-10 Hayashibara Takeshi Preventive and remedy for interferon-sensitive disease
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
ATE52693T1 (de) * 1982-10-25 1990-06-15 Genentech Inc Synergistische humaninterferonaktivitaet.
US4806347A (en) * 1985-12-11 1989-02-21 Schering Corporation Interferon combinations
JPS61263929A (ja) * 1986-04-30 1986-11-21 Hayashibara Takeshi 抗タイプ２インターフェロン感受性疾患剤
US4851219A (en) * 1986-11-18 1989-07-25 Genentech, Inc. Method for the treatment of chronic myelogenous leukemia

Also Published As

Publication number Publication date
EP0276120B1 (de) 1992-04-08
JPS63198636A (ja) 1988-08-17
GR3004928T3 (de) 1993-04-28
ATE74517T1 (de) 1992-04-15
EP0276120A2 (de) 1988-07-27
ES2039276T3 (es) 1993-09-16
CA1321348C (en) 1993-08-17
EP0276120A3 (en) 1989-10-04

Similar Documents

Publication Publication Date Title
NO875355L (no) Rensing av rekombinant beta-interferon innbefattende rp-hplc.
DE3381553D1 (de) Synergistische humaninterferonaktivitaet.
DK0426521T3 (da) Anvendelse af interleukin 2 til behandling af leukæmi
DK201590A (da) Antihypertensiv hyperimmun maelk, fremstilling, sammensaetning og anvendelse
DE3869789D1 (de) Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.
DE3773295D1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
DK50987D0 (da) Polypeptid med plasminogenaktivatorvirkning
DK0388799T3 (da) Anvendelse af human beta-interferon til stimulering af erythropoiesis
DE3780047T2 (de) Verwendung biologisch aktiver polypeptide und diese enthaltende zusammensetzungen.
DE3752184T2 (de) Herstellung und Verwendungen von gamma-Interferon
IL67896A (en) Two biologically active human gama interferon subtypes,purification thereof and pharmaceutical compositions containing them
ATE189262T1 (de) Interferon-alpha/beta bindendes protein, seine herstellung und seine enthaltende pharmazeutische zusammensetzungen
ES2061496T3 (es) Tratamiento intralesional del carcinoma de celulas basales con alfa-interferon humano recombinante.
DE3767175D1 (de) Therapeutische zusammenstellungen auf basis von 3-alkoxyflavonen und derivate von 3-alkoxyflavonen.
DE69104619T2 (de) Verwendungsmethoden von humanem Gammainterferon 4-134.
ATE92333T1 (de) Arzneimittel zur intralesionsbehandlung von schuppenartigem zellkarzinomen mit rekombinantem human-alpha-interferon.
DE3750248T2 (de) Zubereitung und Behandlung der Haut mit Human-Leukocyten-Interferon.
DE3777224D1 (de) Verwendung von interferon-beta und interleukin-2 in der kombinationstherapie und zusammensetzungen dazu.
DK527287D0 (da) Polypeptid med interleukin-2-aktiviteter
ATE73346T1 (de) Verwendung von interferon-beta und interleukin-2 in der kombinationstherapie und zusammensetzungen dazu.
DK0381584T3 (da) Anvendelse af visse gamma-interferoner til behandling af ovariecancer
BR6600321U (pt) Estruturas metalicas de cadeira e mesa
ATE54941T1 (de) Cystein verminderte muteine von biologisch aktiven menschlichen tnf-proteinen.
ES1000854Y (es) Mesa de billar perfeccionada

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation